Interferon Beta-1b for the Treatment of Multiple Sclerosis – More than 10 Years of Experience

Interferon Beta-1b for the Treatment of Multiple Sclerosis – More than 10 Years of Experience

Objective: Interferon beta-1b (IFNβ-1b) was the first disease-modifying agent (DMT) used for the treatment of multiple sclerosis (MS). We aimed to evaluate the first patients with MS that started treatment in our clinic.

Bibliographic Details
Main Authors: Barcutean Laura Iulia, Maier Smaranda, Bajko Zoltan, Motataianu Anca, Romaniuc Andreea, Andone Sebastian Razvan, Balasa Rodica Ioana
Format: Article
Language:English
Published: Sciendo 2019-03-01
Series:Acta Medica Marisiensis
Subjects:
multiple sclerosis
interferonβ-1b
disability
evolution
disease-modifying therapy
Online Access:https://doi.org/10.2478/amma-2019-0003

Internet

https://doi.org/10.2478/amma-2019-0003

Similar Items